Outset Medical, Inc. (NASDAQ:OM) Shares Sold by State Street Corp

State Street Corp lowered its holdings in shares of Outset Medical, Inc. (NASDAQ:OM) by 7.4% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 194,673 shares of the company’s stock after selling 15,500 shares during the period. State Street Corp owned 0.37% of Outset Medical worth $132,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. Huntington National Bank increased its holdings in shares of Outset Medical by 46.2% in the third quarter. Huntington National Bank now owns 63,306 shares of the company’s stock valued at $43,000 after purchasing an additional 20,000 shares during the period. GSA Capital Partners LLP increased its stake in Outset Medical by 924.7% in the 3rd quarter. GSA Capital Partners LLP now owns 1,111,612 shares of the company’s stock valued at $753,000 after buying an additional 1,003,135 shares during the period. Point72 Asia Singapore Pte. Ltd. purchased a new position in Outset Medical during the 2nd quarter worth $259,000. Point72 Asset Management L.P. purchased a new position in Outset Medical during the 2nd quarter worth $827,000. Finally, Millennium Management LLC lifted its stake in shares of Outset Medical by 58.8% in the 2nd quarter. Millennium Management LLC now owns 1,942,899 shares of the company’s stock worth $7,480,000 after acquiring an additional 719,412 shares during the period.

Outset Medical Trading Up 19.7 %

Shares of OM stock opened at $1.40 on Friday. The business’s fifty day moving average price is $0.95 and its 200 day moving average price is $1.56. The firm has a market capitalization of $73.56 million, a PE ratio of -0.51 and a beta of 2.16. The company has a debt-to-equity ratio of 4.12, a current ratio of 6.49 and a quick ratio of 5.04. Outset Medical, Inc. has a 1-year low of $0.44 and a 1-year high of $5.70.

About Outset Medical

Outset Medical, Inc, a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company offers Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings; and manufactures, supports, and distributes for Tablo console, Tablo cartridge, and other consumables.